NO743673L - - Google Patents
Info
- Publication number
- NO743673L NO743673L NO743673A NO743673A NO743673L NO 743673 L NO743673 L NO 743673L NO 743673 A NO743673 A NO 743673A NO 743673 A NO743673 A NO 743673A NO 743673 L NO743673 L NO 743673L
- Authority
- NO
- Norway
- Prior art keywords
- dihydro
- fish
- oxo
- carboxylic acid
- piperazinyl
- Prior art date
Links
- 241000251468 Actinopterygii Species 0.000 claims description 68
- -1 heterocyclic carboxylic acid Chemical class 0.000 claims description 43
- 239000000203 mixture Substances 0.000 claims description 30
- 150000001875 compounds Chemical class 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 208000035473 Communicable disease Diseases 0.000 claims description 17
- 235000005911 diet Nutrition 0.000 claims description 17
- 239000002253 acid Substances 0.000 claims description 16
- 230000037213 diet Effects 0.000 claims description 15
- 231100000252 nontoxic Toxicity 0.000 claims description 15
- 230000003000 nontoxic effect Effects 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 15
- 239000003814 drug Substances 0.000 claims description 11
- 235000013305 food Nutrition 0.000 claims description 11
- 238000011282 treatment Methods 0.000 claims description 11
- 241000894006 Bacteria Species 0.000 claims description 10
- 230000000069 prophylactic effect Effects 0.000 claims description 9
- 239000000725 suspension Substances 0.000 claims description 6
- 238000007654 immersion Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 229940124597 therapeutic agent Drugs 0.000 claims description 5
- RCIMBBZXSXFZBV-UHFFFAOYSA-N piromidic acid Chemical compound N1=C2N(CC)C=C(C(O)=O)C(=O)C2=CN=C1N1CCCC1 RCIMBBZXSXFZBV-UHFFFAOYSA-N 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 150000001735 carboxylic acids Chemical class 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- XVRCWGVHAICWOW-UHFFFAOYSA-N pyrido[2,3-d]pyrimidine-6-carboxylic acid Chemical compound N1=CN=CC2=CC(C(=O)O)=CN=C21 XVRCWGVHAICWOW-UHFFFAOYSA-N 0.000 claims 1
- 125000004943 pyrimidin-6-yl group Chemical group N1=CN=CC=C1* 0.000 claims 1
- 235000019688 fish Nutrition 0.000 description 57
- 241000252229 Carassius auratus Species 0.000 description 13
- 241000252073 Anguilliformes Species 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 208000015181 infectious disease Diseases 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 7
- 208000010824 fish disease Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 239000013505 freshwater Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- ZAMIZBUROFRJHK-UHFFFAOYSA-N 1-ethenyl-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid Chemical compound C1CN(C)CCN1C1=CC=C2C(=O)C(C(O)=O)=CN(C=C)C2=C1 ZAMIZBUROFRJHK-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000607528 Aeromonas hydrophila Species 0.000 description 3
- 241000252087 Anguilla japonica Species 0.000 description 3
- 241000604777 Flavobacterium columnare Species 0.000 description 3
- 241000269908 Platichthys flesus Species 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- 241000607598 Vibrio Species 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 229940127089 cytotoxic agent Drugs 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 244000000010 microbial pathogen Species 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- WTNGOWIKHDGXEJ-UHFFFAOYSA-N 1-ethenyl-7-(4-ethylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid Chemical compound C1CN(CC)CCN1C1=CC=C2C(=O)C(C(O)=O)=CN(C=C)C2=C1 WTNGOWIKHDGXEJ-UHFFFAOYSA-N 0.000 description 2
- 241000607534 Aeromonas Species 0.000 description 2
- 206010001430 Aeromonas infections Diseases 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 241001646999 Corallococcus Species 0.000 description 2
- 241000252233 Cyprinus carpio Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 206010058667 Oral toxicity Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 238000003113 dilution method Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 231100000418 oral toxicity Toxicity 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- IRYAYNRNRAHHDH-UHFFFAOYSA-N 1-ethenyl-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid Chemical compound C=1C=C2C(=O)C(C(=O)O)=CN(C=C)C2=NC=1N1CCNCC1 IRYAYNRNRAHHDH-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241001635206 Conger conger Species 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 241000276457 Gadidae Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001502129 Mullus Species 0.000 description 1
- 241001327682 Oncorhynchus mykiss irideus Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 241000606860 Pasteurella Species 0.000 description 1
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 1
- 241000520869 Pseudomonas anguilliseptica Species 0.000 description 1
- 241000277331 Salmonidae Species 0.000 description 1
- 241000269851 Sarda sarda Species 0.000 description 1
- 241000168311 Sillago Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 description 1
- 241001504592 Trachurus trachurus Species 0.000 description 1
- 241000544286 Vibrio anguillarum Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- JNGZXGGOCLZBFB-IVCQMTBJSA-N compound E Chemical compound N([C@@H](C)C(=O)N[C@@H]1C(N(C)C2=CC=CC=C2C(C=2C=CC=CC=2)=N1)=O)C(=O)CC1=CC(F)=CC(F)=C1 JNGZXGGOCLZBFB-IVCQMTBJSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- PLHJDBGFXBMTGZ-WEVVVXLNSA-N furazolidone Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OCC1 PLHJDBGFXBMTGZ-WEVVVXLNSA-N 0.000 description 1
- 229960001625 furazolidone Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 230000008560 physiological behavior Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960000654 sulfafurazole Drugs 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000007160 ty medium Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Farming Of Fish And Shellfish (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11500673A JPS5647166B2 (it) | 1973-10-13 | 1973-10-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO743673L true NO743673L (it) | 1975-05-12 |
Family
ID=14651943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO743673A NO743673L (it) | 1973-10-13 | 1974-10-11 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3981999A (it) |
| JP (1) | JPS5647166B2 (it) |
| CA (1) | CA1052698A (it) |
| DE (1) | DE2448564C3 (it) |
| FR (1) | FR2247245B1 (it) |
| GB (1) | GB1465993A (it) |
| IE (1) | IE39940B1 (it) |
| IT (1) | IT1022820B (it) |
| NO (1) | NO743673L (it) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03250178A (ja) * | 1990-02-27 | 1991-11-07 | Tostem Corp | ドアの吊車装置 |
| AU2466099A (en) * | 1998-01-23 | 1999-08-09 | Trustees Of Tufts College | Pharmaceutically active compounds and methods of use thereof |
| US7334538B1 (en) * | 2004-07-27 | 2008-02-26 | Aquascience Research Group, Inc. | Topical medicants for aquatic animals |
-
1973
- 1973-10-13 JP JP11500673A patent/JPS5647166B2/ja not_active Expired
-
1974
- 1974-10-08 IE IE2086/74A patent/IE39940B1/xx unknown
- 1974-10-10 GB GB4400074A patent/GB1465993A/en not_active Expired
- 1974-10-10 US US05/513,824 patent/US3981999A/en not_active Expired - Lifetime
- 1974-10-11 DE DE2448564A patent/DE2448564C3/de not_active Expired
- 1974-10-11 IT IT28352/74A patent/IT1022820B/it active
- 1974-10-11 NO NO743673A patent/NO743673L/no unknown
- 1974-10-11 CA CA211,264A patent/CA1052698A/en not_active Expired
- 1974-10-14 FR FR7434486A patent/FR2247245B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| IT1022820B (it) | 1978-04-20 |
| IE39940B1 (en) | 1979-01-31 |
| FR2247245B1 (it) | 1978-07-28 |
| DE2448564A1 (de) | 1975-06-19 |
| DE2448564B2 (de) | 1979-04-05 |
| DE2448564C3 (de) | 1979-11-22 |
| GB1465993A (en) | 1977-03-02 |
| FR2247245A1 (it) | 1975-05-09 |
| CA1052698A (en) | 1979-04-17 |
| JPS5647166B2 (it) | 1981-11-07 |
| IE39940L (en) | 1975-04-13 |
| AU7418774A (en) | 1976-04-15 |
| JPS5064415A (it) | 1975-05-31 |
| US3981999A (en) | 1976-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5259905B2 (ja) | 抗菌剤として適用可能な中鎖脂肪酸 | |
| KR100365151B1 (ko) | 어류 병원성 세균과 바이러스의 감염 예방 및 치료를 위한δ-아미노레불린산의 신규한 용도 | |
| WO2017147130A2 (en) | Direct fed microbial for prevention of shrimp disease | |
| CN109999027B (zh) | 褪黑素的用途 | |
| NO180473B (no) | Fremgangsmåte for fremstilling av et enteralt, farmasöytisk forpreparat for behandling av ektoparasittiske fiskesykdommer | |
| CN1636453A (zh) | 使用醌化合物制备杀生物的组合物和衍生组合物 | |
| RU2310446C2 (ru) | Лечение и профилактика заболеваний и инфекций свиней и домашней птицы | |
| NO743673L (it) | ||
| US3708578A (en) | Composition and method for inhibiting the growth of animal pathogens | |
| US4110467A (en) | Prophylactic, therapeutic or hygienical agent against virus diseases in fish and use therefor | |
| CN105685529A (zh) | 一种预防罗非鱼肠炎的饲料添加剂 | |
| JP2001008636A (ja) | 感染症防止用飼料組成物 | |
| EP3920902A1 (en) | Composition for use in the treatment of piscirickettsiosis | |
| EP0250115A2 (en) | 2,5-Pyrrolidine dione derivatives obtained from bacteriae, and their use as bactericides | |
| US3551566A (en) | Fish disease treating composition and method of using same | |
| CN108992448B (zh) | 一种观赏鱼用含盐除菌片剂及其制备方法 | |
| US4205081A (en) | Composition and method for preventing or treating swine dysentery | |
| CN109464435B (zh) | 一种用于防治鱼类肝脏炎症的药物组合物 | |
| JP3002709B1 (ja) | 冷水病の予防・治療剤及び予防・治療方法 | |
| CN118766954A (zh) | 一种海参苗室霉菌病的防治方法 | |
| JPH041132A (ja) | 魚類の細菌性疾患の予防・治療剤 | |
| EA043988B1 (ru) | Биологически активная кормовая добавка и способ ее получения | |
| EP3806640A1 (en) | Anti-parasitic composition | |
| CN116212000A (zh) | 一种环（l-亮氨酸-d-脯氨酸）二肽的应用及其水产抑菌剂 | |
| KR20190025105A (ko) | 쿠도아충 감염 예방 또는 치료용 천연 사료첨가 조성물 |